CXCL9 and neoplasm: Although CXCR3 is expressed in cytotoxic T cells, several studies demonstrated that CXCL9 and CXCL10 induced migration of CXCR3+ tumor cells [118,119], suggesting that CXCR3+ tumor cells preferentially metastasize to lymph nodes expressing these ligands [118].